- Home
- BYON vs VNDA Comparison
BYON vs VNDA Comparison
Compare BYON & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYON
- VNDA
- Stock Information
- Founded
- BYON 1997
- VNDA 2002
- Country
- BYON United States
- VNDA United States
- Employees
- BYON N/A
- VNDA N/A
- Industry
- BYON Catalog/Specialty Distribution
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- BYON Consumer Discretionary
- VNDA Health Care
- Exchange
- BYON Nasdaq
- VNDA Nasdaq
- Market Cap
- BYON 354.2M
- VNDA 261.7M
- IPO Year
- BYON N/A
- VNDA 2006
- Fundamental
- Price
- BYON $7.15
- VNDA $4.68
- Analyst Decision
- BYON Hold
- VNDA Strong Buy
- Analyst Count
- BYON 8
- VNDA 3
- Target Price
- BYON $10.67
- VNDA $15.33
- AVG Volume (30 Days)
- BYON 2.6M
- VNDA 424.5K
- Earning Date
- BYON 07-28-2025
- VNDA 07-30-2025
- Dividend Yield
- BYON N/A
- VNDA N/A
- EPS Growth
- BYON N/A
- VNDA N/A
- EPS
- BYON N/A
- VNDA N/A
- Revenue
- BYON $1,244,431,000.00
- VNDA $201,351,000.00
- Revenue This Year
- BYON N/A
- VNDA $16.86
- Revenue Next Year
- BYON $12.55
- VNDA $39.78
- P/E Ratio
- BYON N/A
- VNDA N/A
- Revenue Growth
- BYON N/A
- VNDA 13.37
- 52 Week Low
- BYON $3.54
- VNDA $3.81
- 52 Week High
- BYON $15.44
- VNDA $6.37
- Technical
- Relative Strength Index (RSI)
- BYON 61.76
- VNDA 57.93
- Support Level
- BYON $6.48
- VNDA $4.38
- Resistance Level
- BYON $7.37
- VNDA $4.95
- Average True Range (ATR)
- BYON 0.53
- VNDA 0.14
- MACD
- BYON 0.02
- VNDA 0.01
- Stochastic Oscillator
- BYON 74.75
- VNDA 54.39
About BYON Beyond Inc.
Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad number of products, including furniture, decor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.